The Enlarged Board of Appeal (EBA) of the European Patent Office EPO recently decided (G 2/08) on the conditions under which substances and compositions known as such are patentable if claimed for use in a novel and inventive medical treatment.
Ab dem 1. September 2010 wird Israel der 85. Mitgliedsstaat des Madrider Systems zur Internationalen Eintragung von Marken sein, nachdem das israelische Parlament das Protokoll zum Madrider Markenabkommen (PMMA) Anfang Juni ratifiziert hat.
